List of Tables
Table 1. Global Octreotide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Octreotide Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Octreotide Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Octreotide Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Octreotide Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Octreotide Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Octreotide Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Octreotide Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Octreotide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Octreotide Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Octreotide Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Octreotide Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Octreotide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Octreotide Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Octreotide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Octreotide Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Octreotide Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Octreotide Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Octreotide Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Octreotide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Octreotide Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Octreotide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Octreotide Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Octreotide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Octreotide Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Octreotide Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Octreotide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Octreotide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Octreotide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Octreotide Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Octreotide Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Octreotide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Octreotide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Octreotide Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Octreotide Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Octreotide Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Octreotide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Octreotide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Octreotide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Octreotide Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Octreotide Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Octreotide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Octreotide Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Octreotide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Octreotide Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Octreotide Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Octreotide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Octreotide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Octreotide Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Octreotide Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Octreotide Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Octreotide Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Octreotide Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Octreotide Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Octreotide Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Octreotide Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Octreotide Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Octreotide Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Octreotide Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Octreotide Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Octreotide Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Octreotide Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Octreotide Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Octreotide Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Octreotide Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Octreotide Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Octreotide Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Octreotide Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Novartis Octreotide Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Sun Pharmaceutical Company Information
Table 76. Sun Pharmaceutical Description and Business Overview
Table 77. Sun Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sun Pharmaceutical Octreotide Drugs Product
Table 79. Sun Pharmaceutical Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva Octreotide Drugs Product
Table 84. Teva Recent Developments/Updates
Table 85. Gland Pharma Company Information
Table 86. Gland Pharma Description and Business Overview
Table 87. Gland Pharma Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Gland Pharma Octreotide Drugs Product
Table 89. Gland Pharma Recent Developments/Updates
Table 90. Chiesi Farmaceutici S.p.A Company Information
Table 91. Chiesi Farmaceutici S.p.A Description and Business Overview
Table 92. Chiesi Farmaceutici S.p.A Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Chiesi Farmaceutici S.p.A Octreotide Drugs Product
Table 94. Chiesi Farmaceutici S.p.A Recent Developments/Updates
Table 95. Fresenius Kabi Company Information
Table 96. Fresenius Kabi Description and Business Overview
Table 97. Fresenius Kabi Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Fresenius Kabi Octreotide Drugs Product
Table 99. Fresenius Kabi Recent Developments/Updates
Table 100. Mylan Company Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Mylan Octreotide Drugs Product
Table 104. Mylan Recent Developments/Updates
Table 105. Sagent Pharmaceuticals Company Information
Table 106. Sagent Pharmaceuticals Description and Business Overview
Table 107. Sagent Pharmaceuticals Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sagent Pharmaceuticals Octreotide Drugs Product
Table 109. Sagent Pharmaceuticals Recent Developments/Updates
Table 110. West-Ward Pharmaceuticals Company Information
Table 111. West-Ward Pharmaceuticals Description and Business Overview
Table 112. West-Ward Pharmaceuticals Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. West-Ward Pharmaceuticals Octreotide Drugs Product
Table 114. West-Ward Pharmaceuticals Recent Developments/Updates
Table 115. Suzhou Tianma Pharmaceutical Company Information
Table 116. Suzhou Tianma Pharmaceutical Description and Business Overview
Table 117. Suzhou Tianma Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Suzhou Tianma Pharmaceutical Octreotide Drugs Product
Table 119. Suzhou Tianma Pharmaceutical Recent Developments/Updates
Table 120. Sihuan Pharmaceutical Company Information
Table 121. Sihuan Pharmaceutical Description and Business Overview
Table 122. Sihuan Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Sihuan Pharmaceutical Octreotide Drugs Product
Table 124. Sihuan Pharmaceutical Recent Developments/Updates
Table 125. Chengdu Tiantaishan pharmaceutical Company Information
Table 126. Chengdu Tiantaishan pharmaceutical Description and Business Overview
Table 127. Chengdu Tiantaishan pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Chengdu Tiantaishan pharmaceutical Octreotide Drugs Product
Table 129. Chengdu Tiantaishan pharmaceutical Recent Developments/Updates
Table 130. Hybio Pharmaceutical Company Information
Table 131. Hybio Pharmaceutical Description and Business Overview
Table 132. Hybio Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Hybio Pharmaceutical Octreotide Drugs Product
Table 134. Hybio Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Octreotide Drugs Distributors List
Table 138. Octreotide Drugs Customers List
Table 139. Octreotide Drugs Market Trends
Table 140. Octreotide Drugs Market Drivers
Table 141. Octreotide Drugs Market Challenges
Table 142. Octreotide Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Octreotide Drugs
Figure 2. Global Octreotide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Octreotide Drugs Market Share by Type: 2023 & 2030
Figure 4. Injections Product Picture
Figure 5. Oral Capsules Product Picture
Figure 6. Global Octreotide Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Octreotide Drugs Market Share by Application: 2023 & 2030
Figure 8. Neuroendocrine Tumors
Figure 9. Acromegaly
Figure 10. Other
Figure 11. Global Octreotide Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Octreotide Drugs Market Size (2019-2030) & (US$ Million)
Figure 13. Global Octreotide Drugs Sales (2019-2030) & (K Units)
Figure 14. Global Octreotide Drugs Average Price (US$/Unit) & (2019-2030)
Figure 15. Octreotide Drugs Report Years Considered
Figure 16. Octreotide Drugs Sales Share by Manufacturers in 2023
Figure 17. Global Octreotide Drugs Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Octreotide Drugs Players: Market Share by Revenue in Octreotide Drugs in 2023
Figure 19. Octreotide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Octreotide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Octreotide Drugs Sales Market Share by Country (2019-2030)
Figure 22. North America Octreotide Drugs Revenue Market Share by Country (2019-2030)
Figure 23. United States Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Octreotide Drugs Sales Market Share by Country (2019-2030)
Figure 26. Europe Octreotide Drugs Revenue Market Share by Country (2019-2030)
Figure 27. Germany Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Octreotide Drugs Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Octreotide Drugs Revenue Market Share by Region (2019-2030)
Figure 34. China Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Octreotide Drugs Sales Market Share by Country (2019-2030)
Figure 42. Mexico Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Octreotide Drugs Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Octreotide Drugs Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Octreotide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Octreotide Drugs by Type (2019-2030)
Figure 52. Global Revenue Market Share of Octreotide Drugs by Type (2019-2030)
Figure 53. Global Octreotide Drugs Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Octreotide Drugs by Application (2019-2030)
Figure 55. Global Revenue Market Share of Octreotide Drugs by Application (2019-2030)
Figure 56. Global Octreotide Drugs Price (US$/Unit) by Application (2019-2030)
Figure 57. Octreotide Drugs Value Chain
Figure 58. Octreotide Drugs Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
